Capital One Initiates Coverage On Immutep with Overweight Rating, Announces Price Target of $10
Portfolio Pulse from Benzinga Newsdesk
Capital One analyst Naureen Quibria initiates coverage on Immutep (NASDAQ:IMMP) with an Overweight rating and sets a price target of $10.
May 17, 2024 | 3:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Capital One analyst Naureen Quibria has initiated coverage on Immutep with an Overweight rating and a price target of $10.
The initiation of coverage with an Overweight rating and a price target of $10 by a reputable analyst from Capital One is likely to positively impact Immutep's stock price in the short term as it signals confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100